Edition:
India

BioDelivery Sciences International Inc (BDSI.OQ)

BDSI.OQ on NASDAQ Stock Exchange Capital Market

2.90USD
13 Jul 2018
Change (% chg)

-- (--)
Prev Close
$2.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
52,434
52-wk High
$3.60
52-wk Low
$1.70

Chart for

About

BioDelivery Sciences International, Inc. is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications of approved therapeutics to address unmet medical needs using drug delivery technologies. The Company develops pharmaceutical products... (more)

Overall

Beta: 0.86
Market Cap(Mil.): $166.43
Shares Outstanding(Mil.): 55.48
Dividend: --
Yield (%): --

Financials

  BDSI.OQ Industry Sector
P/E (TTM): 262.01 30.93 32.76
EPS (TTM): 0.01 -- --
ROI: 2.67 15.07 14.61
ROE: 9.28 16.60 16.34

BRIEF-BioDelivery Sciences Appoints Herm Cukier As CEO

* BIODELIVERY SCIENCES APPOINTS HERM CUKIER AS CHIEF EXECUTIVE OFFICER

07 May 2018

BRIEF-Broadfin Says Delivered Letter To BioDelivery Sciences With Nominations For Board

* BROADFIN - ON APRIL 27, DELIVERED LETTER TO BIODELIVERY SCIENCES NOMINATING TODD C. DAVIS, PETER S. GREENLEAF, STEPHEN T. WILLS FOR ELECTION TO BOARD

01 May 2018

BRIEF-Broadfin Capital Reports 7.3 Pct Stake In Biodelivery Sciences

April 10 BioDelivery Sciences International Inc :

10 Apr 2018

BRIEF-Biodelivery Sciences Reports Q4 Loss Per Share $0.29

March 15 Biodelivery Sciences International Inc :

16 Mar 2018

BRIEF-Biodelivery Sciences Announces Belbuca Patent Litigation Settlement Agreement With Teva

* BIODELIVERY SCIENCES ANNOUNCES BELBUCA PATENT LITIGATION SETTLEMENT AGREEMENT WITH TEVA

06 Feb 2018

BRIEF-BioDelivery Sciences Announces Launch And Availability Of Belbuca In Canada

* BIODELIVERY SCIENCES ANNOUNCES LAUNCH AND AVAILABILITY OF BELBUCA® IN CANADA Source text for Eikon: Further company coverage:

30 Jan 2018

Earnings vs. Estimates